Company: VCYT
Filing Date: 2025-08-07
Form Type: 10-Q
Source: 0001384101-25-000110
Chunk: 13

Company: VERACYTE, INC.
Filing Date: 2025-08-07
Form: 10-Q
Item: Part I, Item 1
Chunk 13
---
 net6,518 2,755 11,042 5,503 Income (loss) before income taxes1,250 7,361 8,678 5,453 Income tax provision2,230 1,627 2,611 1,583 Net income (loss)$(980)$5,734 $6,067 $3,870 Earnings (loss) per share:Basic$(0.01)$0.07 $0.08 $0.05 Diluted$(0.01)$0.07 $0.08 $0.05 Shares used to compute earnings (loss) per common share:Basic78,391,502 76,538,325 78,210,881 75,649,057 Diluted78,391,502 77,163,149 79,905,121 76,600,079 

The accompanying notes are an integral part of these condensed consolidated financial statements.

2

Table of Contents

VERACYTE, INC.

 Condensed Consolidated Statements of Comprehensive Income (Loss)

 (Unaudited)

 (In thousands)

 Three Months Ended June 30,Six Months Ended June 30, 2025202420252024Net income (loss)$(980)$5,734 $6,067 $3,870 Other comprehensive income (loss):Change in currency translation adjustments16,682 (1,703)24,131 (6,592)Net comprehensive income (loss)$15,702 $4,031 $30,198 $(2,722)

The accompanying notes are an integral part of these condensed consolidated financial statements.

3

VERACYTE, INC.

Condensed Consolidated Statements of Stockholders' Equity

(Unaudited)

(In thousands)

 Common StockAdditionalPaid-inCapitalAccumulated DeficitAccumulated Other Comprehensive LossTotalStockholders'Equity SharesAmountBalance at March 31, 202578,306 $78 $1,660,435 $(436,936)$(28,641)$1,194,936 Issuance of common stock on exercise of stock options and vesting of restricted stock units293 1 1,814 — — 1,815 Tax portion of vested restricted stock units— — (2,381)— — (2,381)Stock-based compensation expense (employee